StreetInsider.com News Articles

FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program

Wed, 29 Apr 2026 18:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection solutions to reduce the spread of harmful pathogens, announces that it has entered into an agreement dated April 28, 2026, with Innovotech Labs Corporation ("Innovotech") (TSXV: IOT) (OTCQB: IOTCF) to support regulatory planning for its coated catheter program.

Under the agreement, Innovotech will conduct regulatory research to determine the appropriate U.S. Food and Drug Administration ("FDA") classification and regulatory pathway for FendX's coated Foley catheter product currently in development. The scope of work will

FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program

Wed, 29 Apr 2026 18:00:00 -0400

FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program

Wed, 29 Apr 2026 18:00:00 -0400

FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program

Wed, 29 Apr 2026 18:00:00 -0400

FendX Engages Galenvs for Pilot Scale-Up Manufacturing of Its Liquid Surface Coating

Wed, 15 Apr 2026 07:00:00 -0400

Project aims to develop a scalable manufacturing process and represents a key next step toward the commercialization of the surface coating

Vancouver, British Columbia--(Newsfile Corp. - April 15, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection solutions to reduce the spread of harmful pathogens, announces the signing of a statement of work ("SOW") dated April 14, 2026 with Galenvs Sciences Inc. ("Galenvs"), a Canadian contract manufacturing and service organization, to initiate pilot-scale manufacturing of FendX's liquid surface coating.

Dr. Carolyn Myers, CEO of FendX states, "This pilot-scale project is an

FendX Engages Galenvs for Pilot Scale-Up Manufacturing of Its Liquid Surface Coating

Wed, 15 Apr 2026 07:00:00 -0400

Project aims to develop a scalable manufacturing process and represents a key next step toward the commercialization of the surface coating

Dr. Carolyn Myers, CEO of FendX states, "This pilot-scale project is an

FendX Provides Corporate Update

Tue, 31 Mar 2026 07:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 31, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company developing technology-based solutions to reduce the spread of harmful pathogens, is pleased to provide a corporate update from Dr. Carolyn Myers, the Company's President and CEO.

Dear FendX Shareholders,

Over the past several months, FendX has achieved meaningful progress across our protective surface coatings portfolio and business development initiatives. Our mission remains clear: to make everyday environments safe by reducing the spread of harmful pathogens on surfaces. As we advance our technologies, we continue to

FendX Provides Corporate Update

Tue, 31 Mar 2026 07:00:00 -0400

Dear FendX Shareholders,

FendX and Aquaox Enter into Collaboration Agreement to Pursue Innovation in Eco-Friendly Antimicrobial Agents

Thu, 22 Jan 2026 17:00:00 -0400

Agreement formalizes initial feasibility phase following previously announced MOU

Vancouver, British Columbia--(Newsfile Corp. - January 22, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company developing technology-based solutions to reduce the spread of harmful pathogens, is pleased to announce it has entered into a collaboration agreement (the "Agreement") dated January 20, 2026 with Aquaox LLC ("Aquaox"), a U.S. based manufacturer of environmentally responsible disinfectants.

The Agreement builds upon the Memorandum of Understanding ("MOU") signed between the Company and Aquaox announced November 18, 2025 and formalizes the initial phase of the

FendX and Aquaox Enter into Collaboration Agreement to Pursue Innovation in Eco-Friendly Antimicrobial Agents

Thu, 22 Jan 2026 17:00:00 -0400

Agreement formalizes initial feasibility phase following previously announced MOU

The Agreement builds upon the Memorandum of Understanding ("MOU") signed between the Company and Aquaox announced November 18, 2025 and formalizes the initial phase of the

FendX Technologies Presenting at the 3rd Annual DealFlow Discovery Conference

Tue, 20 Jan 2026 08:00:00 -0400

ATLANTIC CITY, NJ AND VANCOUVER, BC / ACCESS Newswire / January 20, 2026 / FendX Technologies Inc.(CSE:FNDX)(OTCQB:FDXTF)(FSE:E8D) (the "Company" or "FendX"), an innovative surface protection company developing technology-based solutions to reduce the spread of harmful pathogens, announces that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026.

Carolyn Myers, CEO of FendX, will deliver a company presentation and be available for one-on-one investor meetings throughout the event to discuss the Company's recent developments, growth strategy and investment opportunities.

Event Details:

3rd Annual DealFlow Discovery Conference
The Borgata Hotel, Casino & Spa
Atlantic City,

FendX Technologies Presenting at the 3rd Annual DealFlow Discovery Conference

Tue, 20 Jan 2026 08:00:00 -0400

Event Details:

3rd Annual DealFlow Discovery Conference
The Borgata Hotel, Casino & Spa
Atlantic City,

FendX Provides Corporate Update

Wed, 31 Dec 2025 18:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - December 31, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company developing technology-based solutions to reduce the spread of harmful pathogens, announces that it has extended the term of a consulting agreement, as amended, previously announced June 11, 2025 and November 21, 2025, with a third party branding expert to provide strategic branding and marketing support to the Company. The term of this agreement was extended to May 10, 2026 on the same monthly fee terms with the branding consultant. The Company also

FendX Provides Corporate Update

Wed, 31 Dec 2025 18:00:00 -0400

FendX Provides Corporate Update

Mon, 01 Dec 2025 18:15:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company developing technology-based solutions to reduce the spread of harmful pathogens, announces the completion of its previously disclosed debt settlement from November 21, 2025. The Company issued 34,540 common shares (each, a "Share") at $0.74 per Share to settle $25,560 of debt with arms-length creditors (the "Debt Settlement").

The Company is carrying out the Debt Settlement to improve its financial position by reducing its existing liabilities. The securities issued pursuant to the Debt Settlement are

FendX Provides Corporate Update

Mon, 01 Dec 2025 18:15:00 -0400

The Company is carrying out the Debt Settlement to improve its financial position by reducing its existing liabilities. The securities issued pursuant to the Debt Settlement are

FendX Provides Corporate Update

Fri, 21 Nov 2025 18:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - November 21, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company developing technology-based solutions to reduce the spread of harmful pathogens, is pleased to announce it intends to settle outstanding debts totalling approximately $25,560 owed by the Company to two arms-length consultants for services performed and payable in common shares of the Company, and which will be settled through the issuance of an aggregate of 34,540 common shares ("Shares") at a deemed price of $0.74 per Share. The Company entered into consulting agreements with

FendX Provides Corporate Update

Fri, 21 Nov 2025 18:00:00 -0400

FendX and Aquaox Sign MOU to Pursue Innovation in Sustainable Pathogen Elimination

Tue, 18 Nov 2025 06:30:00 -0400

Strategic partnership to develop advanced formulations of eco-friendly pathogen-elimination agents and expand FendX's hygiene solutions portfolio

Vancouver, British Columbia--(Newsfile Corp. - November 18, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company developing technology-based solutions to reduce the spread of harmful pathogens, is pleased to announce it has signed a Memorandum of Understanding ("MOU") dated November 17, 2025 with Aquaox LLC ("Aquaox"), a U.S. based manufacturer of environmentally responsible disinfectants.

Under the MOU, FendX and Aquaox intend to negotiate and enter into a collaboration and supply agreement (the "Definitive Agreement")

FendX and Aquaox Sign MOU to Pursue Innovation in Sustainable Pathogen Elimination

Tue, 18 Nov 2025 06:30:00 -0400

Strategic partnership to develop advanced formulations of eco-friendly pathogen-elimination agents and expand FendX's hygiene solutions portfolio

Under the MOU, FendX and Aquaox intend to negotiate and enter into a collaboration and supply agreement (the "Definitive Agreement")

FendX Files Provisional Patent for Novel Antimicrobial Nanoparticle Liquid Coating

Wed, 22 Oct 2025 06:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - October 22, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company developing their technology-based solutions to reduce the spread of harmful pathogens and support a cleaner, safer world, is pleased to announce the filing of a provisional patent application with the United States Patent and Trademark Office. The application, titled "Antimicrobial Coating for Long-Lasting Pathogen Control on High-Touch Surfaces", assigned application number 63/936,328, was filed on August 7, 2025, by Drs. Carolyn Myers, Tohid Didar, Leyla Soleymani and Sara Moetakef Imani, with FendX as

FendX Files Provisional Patent for Novel Antimicrobial Nanoparticle Liquid Coating

Wed, 22 Oct 2025 06:00:00 -0400

AI-Powered Pathogen Detection App: Provisional Patent Filed by FendX CEO

Wed, 20 Aug 2025 06:30:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), an innovative surface protection company developing their technology-based solutions to reduce the spread of harmful pathogens and support a cleaner, safer world, is pleased to announce that its CEO, Dr. Carolyn Myers, has filed a provisional patent application with the United States Patent and Trademark Office. The application, titled "AI Adaptive App Pathogen Detection Platform" dated June 25, 2025, will be assigned to FendX as part of its expanding portfolio of hygiene-related technologies.

The invention described in the patent

AI-Powered Pathogen Detection App: Provisional Patent Filed by FendX CEO

Wed, 20 Aug 2025 06:30:00 -0400

The invention described in the patent

FendX Provides Corporate Update

Wed, 13 Aug 2025 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - August 13, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), an innovative surface protection company using their technology to develop product solutions to reduce the spread of harmful pathogens and support a cleaner, safer world, announces that it intends to consolidate the common shares of the Company (each, a "Share") on the basis of ten (10) pre-consolidation Shares for one (1) post-consolidation Share (the "Consolidation").

To optimize the share structure of the Company, the board of directors has approved the Consolidation on the basis that it may attract